Mar 23, 2026 09:03AM
Mar 23, 2026 09:00AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM
Feb 3, 2026 07:30AM
Oct 24, 2025 07:30AM MIRA Pharmaceuticals begins phase 1 dose study for pain drug
Oct 24, 2025 07:30AM
Oct 16, 2025 07:30AM
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM
Sep 22, 2025 08:00AM MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
Sep 16, 2025 07:30AM
Sep 16, 2025 07:30AM
Sep 12, 2025 07:30AM
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 12, 2025 08:32AM MIRA's Ketamir-2 study accepted for publication in peer-reviewed journal
Aug 12, 2025 08:30AM
Jul 30, 2025 07:30AM
Jul 30, 2025 07:30AM
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
Jul 3, 2025 08:02AM
Jul 3, 2025 08:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 08:00AM
Jun 18, 2025 08:31AM
Jun 18, 2025 08:30AM
Jun 17, 2025 04:06PM Mira Pharma (MIRA) says Ketamir-2 has been accepted for publication in Frontiers in Pharmacology
May 28, 2025 08:30AM
May 8, 2025 08:04AM
May 8, 2025 08:00AM
May 6, 2025 08:02AM
May 6, 2025 08:00AM
Apr 23, 2025 08:04AM
Apr 23, 2025 08:00AM MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation
Apr 16, 2025 08:03AM
Apr 16, 2025 08:00AM
Apr 1, 2025 08:00AM
Mar 24, 2025 07:33AM
Mar 24, 2025 07:30AM
Jun 8, 2016 08:01AM

1,158,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All